The Microplastics Safety Act directs the Food and Drug Administration (FDA) to study and report on how exposure to microplastics in food and drinking water affects human health. The study must examine how people are exposed to microplastics and their potential impacts on children, the endocrine system, cancer risk, chronic illness, and reproductive health, along with other relevant health areas the FDA deems important. The legislation affects consumers and public health by establishing a baseline understanding of microplastics' health risks, which currently remain largely unclear. The FDA must complete the study and submit a report to Congress within one year of the bill's enactment, including recommendations for any new laws or regulatory actions needed to address these health concerns. No specific funding amount is designated in the bill, though it assigns the research responsibilities to the existing FDA.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.